MedPath

Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women With Breast Ultrasound BI-RADS 4 Grade

Not yet recruiting
Conditions
Breast Cancer
Interventions
Diagnostic Test: Detect VOCs in exhaled gas
Registration Number
NCT06489158
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

1. Explore VOCs indicators that can effectively distinguish between benign and malignant breast diseases.

2. The accuracy of VOCs indicators and ultrasound 4a/4b/4c diagnosis will be compared in determining benign and malignant diseases based on pathological gold standards.

Detailed Description

Inclusion Criteria:

Ultrasound examination within 3 months clearly indicates that breast lesions are BI-RADs4a/4b/4c Surgical treatment within one week after Exhaled VOC test informed consent form should be signed

Exclusion Criteria:

Male Women who have been diagnosed as breast cancer by puncture Individuals with unclear BI-RADs level information by breast ultrasound, including but not limited to BI-RADs 4/3-4a/4a-b/4b-c Pregnant or lactating women A positive smoking history within one year Medical history of malignant tumor, including but not limited to breast cancer (excluding skin basal cell carcinoma) The past history of metabolic diseases, including diabetes, gout, etc Respiratory diseases that have been clearly diagnosed in the past, such as asthma and chronic obstructive pulmonary emphysema, are not suitable for participation in the study Previously diagnosed digestive system diseases, such as Helicobacter pylori positivity and gastric ulcers, are not suitable for participation in the study Combination application of drugs related to the treatment of elderly dementia Possible cases which researchers believe it is not suitable for this clinical research

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
168
Inclusion Criteria
  • Ultrasound examination within 3 months clearly indicates that breast lesions are BI-RADs4a/4b/4c
  • Surgical treatment within one week after Exhaled VOC test
  • informed consent form should be signed
Exclusion Criteria
  • Male
  • Women who have been diagnosed as breast cancer by puncture
  • Individuals with unclear BI-RADs level information by breast ultrasound, including but not limited to BI-RADs 4/3-4a/4a-b/4b-c
  • Pregnant or lactating women
  • A positive smoking history within one year
  • Medical history of malignant tumor, including but not limited to breast cancer (excluding skin basal cell carcinoma)
  • The past history of metabolic diseases, including diabetes, gout, etc
  • Respiratory diseases that have been clearly diagnosed in the past, such as asthma and chronic obstructive pulmonary emphysema, are not suitable for participation in the study
  • Previously diagnosed digestive system diseases, such as Helicobacter pylori positivity and gastric ulcers, are not suitable for participation in the study
  • Combination application of drugs related to the treatment of elderly dementia
  • Possible cases which researchers believe it is not suitable for this clinical research

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Benign breast diseaseDetect VOCs in exhaled gasThe accuracy of VOCs indicators and ultrasound 4a/4b/4c diagnosis will be compared in determining benign and malignant diseases based on pathological gold standards.
Breast CancerDetect VOCs in exhaled gasThe accuracy of VOCs indicators and ultrasound 4a/4b/4c diagnosis will be compared in determining benign and malignant diseases based on pathological gold standards.
Primary Outcome Measures
NameTimeMethod
Exhaled VOC Biomarkers1 year

The relationship between exhaled VOC and breast cancer grading will be studied. 168 patients with With Breast Ultrasound BI-RADS 4 Grade were enrolled. Exhale gas was collected and tested using mass spectrometer. Exhaled VOC biomarkers characteristics in admitted women with breast ultrasound BI-RADS 4 grade will be investigated.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

41 Damucang Hutong, Xicheng District

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath